Rahmatullah Rahmati, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Salivary Gland Calculi | 3 | 2017 | 16 | 1.570 |
Why?
|
Sialadenitis | 1 | 2022 | 45 | 0.820 |
Why?
|
Xerostomia | 1 | 2022 | 94 | 0.810 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2020 | 39 | 0.720 |
Why?
|
Endoscopy | 5 | 2022 | 1834 | 0.710 |
Why?
|
Carcinoma, Squamous Cell | 7 | 2020 | 4023 | 0.620 |
Why?
|
Tonsillar Neoplasms | 1 | 2014 | 50 | 0.460 |
Why?
|
Salivary Gland Diseases | 1 | 2013 | 37 | 0.430 |
Why?
|
Tonsillectomy | 1 | 2014 | 268 | 0.370 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 3024 | 0.340 |
Why?
|
Nicotine | 1 | 2014 | 677 | 0.340 |
Why?
|
Anesthesia | 1 | 2017 | 1582 | 0.260 |
Why?
|
Otolaryngology | 3 | 2020 | 685 | 0.240 |
Why?
|
Job Application | 2 | 2020 | 38 | 0.230 |
Why?
|
Salivary Ducts | 1 | 2022 | 25 | 0.210 |
Why?
|
Smoking Cessation | 1 | 2014 | 2055 | 0.210 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2020 | 491 | 0.200 |
Why?
|
Personnel Selection | 2 | 2020 | 194 | 0.190 |
Why?
|
Gingival Neoplasms | 1 | 2019 | 20 | 0.170 |
Why?
|
Verbal Behavior | 1 | 2021 | 335 | 0.170 |
Why?
|
Maxillary Neoplasms | 1 | 2019 | 47 | 0.170 |
Why?
|
Palate, Hard | 1 | 2019 | 58 | 0.170 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1097 | 0.160 |
Why?
|
Neck Dissection | 1 | 2019 | 201 | 0.150 |
Why?
|
Salivary Gland Neoplasms | 1 | 2021 | 304 | 0.150 |
Why?
|
Parotid Neoplasms | 1 | 2019 | 157 | 0.150 |
Why?
|
Nuclear Medicine | 1 | 2020 | 236 | 0.140 |
Why?
|
Pharyngeal Diseases | 1 | 2018 | 134 | 0.140 |
Why?
|
Thyroid Neoplasms | 2 | 2020 | 2332 | 0.140 |
Why?
|
Osteoradionecrosis | 1 | 2016 | 51 | 0.130 |
Why?
|
Wound Closure Techniques | 1 | 2016 | 87 | 0.130 |
Why?
|
Pharyngectomy | 1 | 2015 | 44 | 0.120 |
Why?
|
Tumor Burden | 1 | 2020 | 1893 | 0.120 |
Why?
|
Fistula | 1 | 2016 | 214 | 0.120 |
Why?
|
Thyroidectomy | 1 | 2020 | 902 | 0.120 |
Why?
|
Operating Rooms | 1 | 2021 | 789 | 0.120 |
Why?
|
Osteosarcoma | 1 | 2020 | 897 | 0.120 |
Why?
|
Lymphoproliferative Disorders | 1 | 2018 | 533 | 0.120 |
Why?
|
Ophthalmology | 1 | 2020 | 549 | 0.110 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2014 | 70 | 0.110 |
Why?
|
Thyroid Gland | 1 | 2020 | 1168 | 0.110 |
Why?
|
Treatment Outcome | 5 | 2022 | 64378 | 0.110 |
Why?
|
Medical Errors | 1 | 2021 | 1255 | 0.100 |
Why?
|
Tongue Neoplasms | 1 | 2014 | 183 | 0.100 |
Why?
|
Neoplasm Staging | 5 | 2021 | 11152 | 0.100 |
Why?
|
Free Tissue Flaps | 1 | 2016 | 327 | 0.100 |
Why?
|
Pharynx | 1 | 2014 | 432 | 0.090 |
Why?
|
Anesthesiology | 1 | 2021 | 1114 | 0.090 |
Why?
|
Vasoconstrictor Agents | 1 | 2014 | 651 | 0.090 |
Why?
|
Analysis of Variance | 2 | 2020 | 6234 | 0.090 |
Why?
|
Internship and Residency | 2 | 2020 | 5865 | 0.090 |
Why?
|
Anesthesia, General | 1 | 2017 | 1165 | 0.090 |
Why?
|
Carcinoma | 1 | 2021 | 2330 | 0.090 |
Why?
|
Patient Care Team | 1 | 2021 | 2504 | 0.080 |
Why?
|
Radiotherapy | 1 | 2016 | 1504 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1791 | 0.080 |
Why?
|
Papillomaviridae | 1 | 2015 | 1120 | 0.080 |
Why?
|
Male | 14 | 2022 | 358747 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2925 | 0.080 |
Why?
|
Lung Transplantation | 1 | 2018 | 1305 | 0.080 |
Why?
|
Retrospective Studies | 9 | 2021 | 80168 | 0.080 |
Why?
|
Cervical Vertebrae | 1 | 2014 | 977 | 0.070 |
Why?
|
Humans | 22 | 2022 | 758406 | 0.070 |
Why?
|
Middle Aged | 10 | 2022 | 219568 | 0.070 |
Why?
|
Papillomavirus Infections | 2 | 2020 | 1612 | 0.070 |
Why?
|
Students, Medical | 1 | 2020 | 1927 | 0.070 |
Why?
|
Communication | 1 | 2021 | 3846 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3617 | 0.070 |
Why?
|
Surgical Flaps | 1 | 2014 | 1669 | 0.060 |
Why?
|
Head and Neck Neoplasms | 2 | 2016 | 2882 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8426 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6821 | 0.060 |
Why?
|
Female | 12 | 2020 | 390323 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13468 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2014 | 3485 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3671 | 0.050 |
Why?
|
Survival Analysis | 1 | 2014 | 10112 | 0.050 |
Why?
|
Prognosis | 3 | 2021 | 29557 | 0.050 |
Why?
|
Aptitude Tests | 1 | 2020 | 20 | 0.050 |
Why?
|
United States | 5 | 2020 | 72136 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12096 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8611 | 0.040 |
Why?
|
Cohort Studies | 3 | 2020 | 41256 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14641 | 0.040 |
Why?
|
Salivary Glands | 1 | 2020 | 229 | 0.040 |
Why?
|
Survival Rate | 3 | 2019 | 12721 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14490 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9273 | 0.040 |
Why?
|
Smoking | 1 | 2014 | 9051 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10146 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2020 | 536 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 553 | 0.040 |
Why?
|
Paranasal Sinus Diseases | 1 | 2018 | 121 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2020 | 1032 | 0.030 |
Why?
|
Skull | 1 | 2020 | 815 | 0.030 |
Why?
|
Mandible | 1 | 2020 | 750 | 0.030 |
Why?
|
Surgical Wound Dehiscence | 1 | 2016 | 216 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 596 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2020 | 2850 | 0.030 |
Why?
|
Self Concept | 1 | 2020 | 1041 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2020 | 2676 | 0.030 |
Why?
|
Risk Assessment | 1 | 2014 | 23884 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2018 | 856 | 0.030 |
Why?
|
Neck Pain | 1 | 2014 | 186 | 0.030 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2014 | 286 | 0.020 |
Why?
|
Vasoconstriction | 1 | 2014 | 592 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2014 | 413 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4901 | 0.020 |
Why?
|
Adult | 4 | 2020 | 219935 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3099 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2016 | 1268 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 73809 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 25956 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 2018 | 1274 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8530 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8553 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6768 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20500 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39059 | 0.020 |
Why?
|
Contrast Media | 1 | 2018 | 5298 | 0.010 |
Why?
|
Clinical Competence | 1 | 2020 | 4775 | 0.010 |
Why?
|
Spinal Fusion | 1 | 2014 | 1280 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 7980 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12951 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58683 | 0.010 |
Why?
|
Aged | 3 | 2019 | 168218 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2020 | 15637 | 0.010 |
Why?
|
Child | 1 | 2014 | 79818 | 0.000 |
Why?
|